Oramed Pharmaceuticals

ORMP

Börsenwert 173 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Renaissance Technologies New York	395.000 $	-121.153 $	-16.700	-24 %
2	2 Barclays London, United Kingdom	306.000 $	–	–	–
3	3 Morgan Stanley New York	219.000 $	-32.269 $	-4.448	-13 %
4	4 BlackRock New York	209.000 $	+203.429 $	+28.041	Neu
5	5 PNC Financial Services Group Pittsburgh, Pennsylvania	158.000 $	–	–	–
6	6 Glenmede Trust Philadelphia, Pennsylvania	149.000 $	–	–	–
7	7 Deutsche Bank Frankfurt Am Main Ge, Germany	131.000 $	-53.061 $	-7.314	-29 %
8	8 Rossmore Private Capital Glastonbury, Connecticut	112.000 $	–	–	–
9	9 Wells Fargo San Francisco, California	80.000 $	+18.862 $	+2.600	+32 %
10	10 UBS Group Zurich, Switzerland	61.000 $	-4.716 $	-650	-7 %
11	11 Citigroup New York	55.000 $	+6.203 $	+855	+13 %
12	12 Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania	23.000 $	–	–	–
13	13 Bank of Montreal Toronto, Ontario, Canada	19.000 $	–	–	–
14	14 Royal Bank of Canada Toronto, Ontario, Canada	11.000 $	–	–	–
15	15 Bank of America Charlotte, North Carolina	8.000 $	–	–	–
16	16 Advisor Group Phoenix, Arizona	7.000 $	+7.255 $	+1.000	Neu
17	17 Close Asset Management London, United Kingdom	5.000 $	–	–	–
18	18 JFS Wealth Advisors Hermitage, Pennsylvania	4.000 $	–	–	–
19	19 Ladenburg Thalmann Financial Services Miami, Florida	3.000 $	–	–	–
20	20 Steward Partners Investment Advisory New York	2.000 $	–	–	–
21	21 Landaas & Company Milwaukee, Wisconsin	2.000 $	+1.669 $	+230	Neu
22	22 ETF Managers Group Summit, New Jersey	–	-86.000 $	-13.478	Geschlossen
23	23 Financial Architects (New Jersey) Marlton, New Jersey	–	-18.000 $	-2.750	Geschlossen
24	24 Tower Research Capital (TRC) New York	–	-2.000 $	-281	Geschlossen

Oramed Pharmaceuticals ORMP Börsenwert 173 Mio. $

Oramed Pharmaceuticals

ORMP

Börsenwert 173 Mio. $